Developmental origins of brain tumors

Current Opinion in Neurobiology

Volumn 22, Issue 5, 2012, Pages 844-849

  Liu, Chong ^a   Zong, Hui ^a  

^a UNIVERSITY OF OREGON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

CARCINOGENESIS; CELL DIFFERENTIATION; CELL MUTANT; CELL TRANSFORMATION; CELL TYPE; CONCEPTUAL FRAMEWORK; EPENDYMOMA; FATALITY; GENE MUTATION; GENETIC MODEL; GLIOBLASTOMA; HUMAN; MEDULLOBLASTOMA; NEURAL STEM CELL; NONHUMAN; OLIGODENDROCYTE PROGENITOR CELL; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STEM CELL;

ANIMALS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; EPENDYMOMA; GLIOMA; HUMANS; MEDULLOBLASTOMA; MICE; MUTATION; NEOPLASTIC STEM CELLS; STEM CELLS;

EID: 84868205249     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2012.04.012     Document Type: Review

References (37)

1. Visvader J.E. Cells of origin in cancer. Nature 2011, 469:314-322.
2. Fuller G.N. The WHO classification of tumours of the central nervous system, 4th edition. Arch Pathol Lab Med 2008, 132:906.
3. Kleihues P., Louis D.N., Scheithauer B.W., Rorke L.B., Reifenberger G., Burger P.C., Cavenee W.K. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002, 61:215-225. discussion 226-219.
4. Modena P., Lualdi E., Facchinetti F., Veltman J., Reid J.F., Minardi S., Janssen I., Giangaspero F., Forni M., Finocchiaro G., et al. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 2006, 24:5223-5233.
5. Taylor M.D., Poppleton H., Fuller C., Su X., Liu Y., Jensen P., Magdaleno S., Dalton J., Calabrese C., Board J., et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005, 8:323-335.
6. Johnson R.A., Wright K.D., Poppleton H., Mohankumar K.M., Finkelstein D., Pounds S.B., Rand V., Leary S.E., White E., Eden C., et al. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 2010, 466:632-636.
7. Sharma M.K., Mansur D.B., Reifenberger G., Perry A., Leonard J.R., Aldape K.D., Albin M.G., Emnett R.J., Loeser S., Watson M.A., et al. Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res 2007, 67:890-900.
8. Gilbertson R.J., Ellison D.W. The origins of medulloblastoma subtypes. Annu Rev Pathol 2008, 3:341-365.
9. Schuller U., Heine V.M., Mao J., Kho A.T., Dillon A.K., Han Y.G., Huillard E., Sun T., Ligon A.H., Qian Y., et al. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 2008, 14:123-134.
10. Yang Z.J., Ellis T., Markant S.L., Read T.A., Kessler J.D., Bourboulas M., Schuller U., Machold R., Fishell G., Rowitch D.H., et al. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 2008, 14:135-145.
11. Gibson P., Tong Y., Robinson G., Thompson M.C., Currle D.S., Eden C., Kranenburg T.A., Hogg T., Poppleton H., Martin J., et al. Subtypes of medulloblastoma have distinct developmental origins. Nature 2010, 468:1095-1099.
12. Verhaak R.G., Hoadley K.A., Purdom E., Wang V., Qi Y., Wilkerson M.D., Miller C.R., Ding L., Golub T., Mesirov J.P., et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17:98-110.
13. Doetsch F., Caille I., Lim D.A., Garcia-Verdugo J.M., Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999, 97:703-716.
14. Ming G.L., Song H. Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 2011, 70:687-702.
15. Gage F.H. Mammalian neural stem cells. Science 2000, 287:1433-1438.
16. Nishiyama A., Komitova M., Suzuki R., Zhu X. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci 2009, 10:9-22.
17. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
18. Beier D., Hau P., Proescholdt M., Lohmeier A., Wischhusen J., Oefner P.J., Aigner L., Brawanski A., Bogdahn U., Beier C.P. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007, 67:4010-4015.
19. Zhu Y., Guignard F., Zhao D., Liu L., Burns D.K., Mason R.P., Messing A., Parada L.F. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell 2005, 8:119-130.
20. Zheng H., Ying H., Yan H., Kimmelman A.C., Hiller D.J., Chen A.J., Perry S.R., Tonon G., Chu G.C., Ding Z., et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 2008, 455:1129-1133.
21. Wang Y., Yang J., Zheng H., Tomasek G.J., Zhang P., McKeever P.E., Lee E.Y., Zhu Y. Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell 2009, 15:514-526.
22. Ligon K.L., Huillard E., Mehta S., Kesari S., Liu H., Alberta J.A., Bachoo R.M., Kane M., Louis D.N., Depinho R.A., et al. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 2007, 53:503-517.
23. Bachoo R.M., Maher E.A., Ligon K.L., Sharpless N.E., Chan S.S., You M.J., Tang Y., DeFrances J., Stover E., Weissleder R., et al. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 2002, 1:269-277.
24. Alcantara Llaguno S., Chen J., Kwon C.H., Jackson E.L., Li Y., Burns D.K., Alvarez-Buylla A., Parada L.F. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009, 15:45-56.
25. Ligon K.L., Alberta J.A., Kho A.T., Weiss J., Kwaan M.R., Nutt C.L., Louis D.N., Stiles C.D., Rowitch D.H. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol 2004, 63:499-509.
26. Weiss W.A., Burns M.J., Hackett C., Aldape K., Hill J.R., Kuriyama H., Kuriyama N., Milshteyn N., Roberts T., Wendland M.F., et al. Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Res 2003, 63:1589-1595.
27. Persson A.I., Petritsch C., Swartling F.J., Itsara M., Sim F.J., Auvergne R., Goldenberg D.D., Vandenberg S.R., Nguyen K.N., Yakovenko S., et al. Non-stem cell origin for oligodendroglioma. Cancer Cell 2010, 18:669-682.
28. Lei L., Sonabend A.M., Guarnieri P., Soderquist C., Ludwig T., Rosenfeld S., Bruce J.N., Canoll P. Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype. PLoS ONE 2011, 6:e20041.
29. Lindberg N., Kastemar M., Olofsson T., Smits A., Uhrbom L. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene 2009, 28:2266-2275.
30. Zhu X., Bergles D.E., Nishiyama A. NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development 2008, 135:145-157.
31. Liu C., Sage J.C., Miller M.R., Verhaak R.G., Hippenmeyer S., Vogel H., Foreman O., Bronson R.T., Nishiyama A., Luo L., et al. Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 2011, 146:209-221.
32. Barrett L.E., Granot Z., Coker C., Iavarone A., Hambardzumyan D., Holland E.C., Nam H.S., Benezra R. Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. Cancer Cell 2012, 21:11-24.
33. Zong H., Espinosa J.S., Su H.H., Muzumdar M.D., Luo L. Mosaic analysis with double markers in mice. Cell 2005, 121:479-492.
34. Muzumdar M., Luo L., Zong H. Modeling sporadic loss of heterozygosity in mice by using mosaic analysis with double markers (MADM). Proc Natl Acad Sci USA 2007, 104:4495-4500.
35. Tasic B., Miyamichi K., Hippenmeyer S., Dani V.S., Zeng H., Joo W., Zong H., Chen-Tsai Y., Luo L. Extensions of MADM (Mosaic Analysis with Double Markers) in mice. PLoS ONE 2012, 7:e33332.
36. Carro M.S., Lim W.K., Alvarez M.J., Bollo R.J., Zhao X., Snyder E.Y., Sulman E.P., Anne S.L., Doetsch F., Colman H., et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 2010, 463:318-325.
37. Bhat K.P., Salazar K.L., Balasubramaniyan V., Wani K., Heathcock L., Hollingsworth F., James J.D., Gumin J., Diefes K.L., Kim S.H., et al. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev 2011, 25:2594-2609.